Health
Synthetic nanobodies show potential for new COVID-19 therapies – The Science Board
Synthetic nanobodies may provide a practical avenue for the development of novel COVID-19 therapies compared to human antibodies, which are bulkier and require…
As there are currently no clinically validated vaccines and limited therapeutic treatments for SARS-CoV-2, developing new therapeutics is a worldwide endeavor, with neutralizing antibodies as a central component. However, traditional antibody production suffers from long development times and costly production.
As an alternative to human antibodies, nanobodies (single-domain antibodies) offer a promising approach, conferring the benefits of small size, increased stability, and superior simplicity…
-
General15 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business23 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business22 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General22 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips